Combination antiemetic therapy with aprepitant/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy (SENRI trial): a multicentre, randomised, controlled phase 3 trial. (Q50923353)
Jump to navigation
Jump to search
scientific article published on 24 April 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combination antiemetic therapy with aprepitant/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy (SENRI trial): a multicentre, randomised, controlled phase 3 trial. |
scientific article published on 24 April 2015 |
Statements
1 reference
Combination antiemetic therapy with aprepitant/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy (SENRI trial): a multicentre, randomised, controlled phase 3 trial. (English)
1 reference
1 reference
Masaki Mori
1 reference
Yuichiro Doki
1 reference
Hirofumi Yamamoto
1 reference
Mamoru Uemura
1 reference
Taishi Hata
1 reference
Ichiro Takemasa
1 reference
Tsunekazu Mizushima
1 reference
Taroh Satoh
1 reference
Mitsugu Sekimoto
1 reference
Toshihiro Kudo
1 reference
Shunji Morita
1 reference
Takayuki Fukuzaki
1 reference
Riichiro Nezu
1 reference
Ken Nakata
1 reference
Mutsumi Fukunaga
1 reference
Yoshihito Ide
1 reference
Yasuhiro Miyake
1 reference
Yuko Ohno
1 reference
Hiroyoshi Takemoto
1 reference
Multi-center Clinical Study Group of Osaka, Colorectal Cancer Treatment Group (MCSGO)
1 reference
Masayoshi Yasui
1 reference
Daisuke Sakai
1 reference
24 April 2015
1 reference
51
1 reference
1274-1282
1 reference
10
1 reference
Identifiers
1 reference